PODD — INSULET CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1145197 ·
Last close
$136.13
Market Cap
$9.44B
52W High
$354.88
52W Low
$126.40
ADV30
1,629,363
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 761,700,000 | 529,100,000 | 122,200,000 | 91,100,000 | 2,987,200,000 | 480,400,000 | 1,684,600,000 |
| Dec 2025 | 783,800,000 | 568,600,000 | 146,300,000 | 101,600,000 | 3,190,400,000 | 716,100,000 | 1,675,100,000 |
| Sep 2025 | 706,300,000 | 510,100,000 | 117,700,000 | 87,600,000 | 3,029,300,000 | 757,500,000 | 1,645,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$619,200,000
Investing CF
$-234,700,000
Financing CF
$-1,192,800,000
CapEx
$-231,500,000
Dividends Paid
—
Buybacks
$-359,600,000
EPS Diluted TTM
$5.35
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$378,500,000
Inventory
$462,500,000
Receivables
$544,600,000
ST Investments
—
EBIT TTM
$469,200,000
Pretax Income TTM
$404,400,000
Interest Exp TTM
$64,800,000
Analysts
22
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,053,400,064
EBITDA
$614,899,968
Free Cash Flow
$236,900,000
Enterprise Value
$9,565,479,936
Total Cash
$534,900,000
Total Debt
$948,400,000
Shares Out
69,354,199
Trailing EPS
$5.33
Book Value
$20.51
ROE
26.0%
ROA
9.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,708,100,000 | 473,800,000 | 247,100,000 | 3,190,400,000 | — | 1,515,300,000 | 569,300,000 |
| Dec 2024 | 2,071,600,000 | 308,900,000 | 418,300,000 | 3,087,700,000 | 1,876,100,000 | 1,211,600,000 | 430,200,000 |
| Dec 2023 | 1,697,100,000 | 220,100,000 | 206,300,000 | 2,588,200,000 | 1,855,500,000 | 732,700,000 | 145,700,000 |
| Dec 2022 | 1,305,300,000 | 37,600,000 | 4,600,000 | 2,251,100,000 | 1,774,700,000 | 476,400,000 | 119,000,000 |
| Dec 2021 | — | — | — | — | 1,492,500,000 | — | — |
TTM Snapshot
Revenues TTM
$1,886,400,000
NetIncome TTM
$159,600,000
OpCashFlow TTM
$0
Assets (Latest)
$3,190,400,000
Forward EPS
$7.71
Max Pain — expiry 2026-12-18
max pain strike: $150.00 · spot: $133.11 · call oi: 1,846 · put oi: 2,946
Expected Move to 2026-12-18:
±$23.40
(17.58%) —
implied range
$109.71 –
$156.51
· ATM straddle on $135.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GKOS | GLAUKOS Corp | $9.11B | $154.43 | — |
| ALGN | ALIGN TECHNOLOGY INC | $10.43B | $146.78 | — |
| GMED | GLOBUS MEDICAL INC | $8.33B | $74.52 | — |
| SNN | SMITH & NEPHEW PLC | $11.26B | $26.91 | — |
| BAX | BAXTER INTERNATIONAL INC | $12.08B | $23.37 | — |
News headlines (Yahoo Finance, 1h cache)
Insulet (PODD) Stock May Trade At A Discount To Fair Value
2026-09-26 05:10 · Yahoo
Insulet (PODD) Reworked Its Debt, Is The Stock Still Cheap?
2026-09-25 11:12 · Yahoo
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum
2026-09-25 08:02 · Yahoo
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
2026-09-24 08:18 · Yahoo
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum
2026-09-18 11:00 · Yahoo
BCSM Exits Insulet Corporation (PODD), Maintains Watchlist Status
2026-09-17 12:48 · Yahoo
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
2026-09-08 13:24 · Yahoo
Artisan Sold Insulet (PODD) Due to Competition Concerns
2026-09-08 13:00 · Yahoo
Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?
2026-09-04 15:30 · Yahoo
Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks
2026-09-04 00:39 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.